Sunovion Pharmaceuticals Inc. Employee Transition Retirement Benefit Plan — Form 5500 plan (Sunovion Pharmaceuticals Inc.)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Sunovion Pharmaceuticals Inc. Employee Transition Retirement Benefit Plan is a benefit plan reported by Sunovion Pharmaceuticals Inc. under EIN 22-2536587 and plan number 503. The latest loaded filing year is 2023. The filing reports 1,355 participants and not reported in the loaded dataset in end-of-year plan assets, where available in the loaded dataset.
Form 5500 plan profile · 2023
Key reported metrics
Net assets (EOY)Not reported
Participants1.4KCovered participants reported1,355
Assets / participantNot reported
Provider compensationNone reported
- Plan sponsor
- Sunovion Pharmaceuticals Inc.
- EIN
- 22-2536587
- Plan number
- 503
- Plan type
- 2
- Location
- Marlborough, MA
- Latest filing year
- 2023
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 1,355 | — | 20240415100005NAL0003320530001 |
Reported financial statement
This plan is loaded, but Schedule H / I financial-statement detail is not present for it in the current loaded dataset.
Service provider compensation (Schedule C)
No Schedule C service provider compensation is loaded for this plan yet.